Raymond Douglas, MD, PhD, director of the orbital and thyroid eye disease program, Cedars-Sinai Medical Center, discusses the treatment efficacy of Tepezza (teprotumumab) in a variety of patients with thyroid eye disease, including how this...
Raymond Douglas, MD, PhD, director of the orbital and thyroid eye disease program, Cedars-Sinai Medical Center, discusses the treatment efficacy of Tepezza (teprotumumab) in a variety of patients with thyroid eye disease, including how this...
Raymond Douglas, MD, PhD,...